The content is available as a PDF (169.5 KB).
COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations
Michael P Lunn
David R Cornblath
Bart C Jacobs
Luis Querol
Peter A van Doorn
Richard A Hughes
Hugh J Willison
Correspondence to: Michael P. Lunn, E-mail: michaellunn@nhs.net
Received 2020 Nov 23; Revised 2020 Nov 30; Accepted 2020 Dec 4.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)